Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  Cochlear Limited    COH   AU000000COH5

COCHLEAR LIMITED

(COH)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths
  • Share prices are approaching a strong support area in daily data, which offers good timing for investors.
  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 39% by 2023.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
Weaknesses
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 59.86 times its estimated earnings per share for the ongoing year.
  • The company is not the most generous with respect to shareholders' compensation.
  • Most analysts recommend that the stock should be sold or reduced.
Ratings chart
Sector Medical Equipment, Supplies & Distribution
1st jan.Capitalisation (M$)Investor Rating
COCHLEAR LIMITED0.95%9 682
ABBOTT LABORATORIES1.65%188 543
MEDTRONIC PLC-0.28%158 521
STRYKER CORPORATION-1.24%90 990
BECTON, DICKINSON AND COMPA..4.60%74 973
HOYA CORPORATION-2.24%49 992
ALIGN TECHNOLOGY, INC.6.15%43 734
IDEXX LABORATORIES, INC.-2.08%41 703
BAXTER INTERNATIONAL INC.-0.25%40 891
ALCON INC.5.30%34 642
SARTORIUS STEDIM BIOTECH6.46%33 925
DEXCOM, INC.-4.20%33 809
ZIMMER BIOMET HOLDINGS3.91%33 708
TERUMO CORPORATION-4.06%30 870
COLOPLAST A/S-4.54%30 821
SYSMEX CORPORATION3.63%26 109
More Results
Financials
Sales 2021 1 465 M 1 128 M 1 128 M
Net income 2021 199 M 154 M 154 M
Net cash 2021 262 M 202 M 202 M
P/E ratio 2021 59,9x
Yield 2021 0,56%
Capitalization 12 544 M 9 682 M 9 661 M
EV / Sales 2021 8,38x
EV / Sales 2022 7,19x
Nbr of Employees 4 000
Free-Float 99,4%
Upcoming event on COCHLEAR LIMITED
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes